Potential of Low-Dose Carbon Monoxide in Promoting Osseointegration

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Nanotechnology

Background:

• Osseointegration is vital for dental implant stability but hindered by infection and inflammation.
• Carbon monoxide (CO) shows therapeutic potential, but clinical use is limited by dose control issues.

Purpose of the Study:

• To develop a photo-responsive implant system for controlled CO release.
• To evaluate the efficacy of CO in enhancing osseointegration and bone healing.

Main Methods:

• A polyetheretherketone (PEEK)-based implant system with immobilized manganese carbonyl nanocrystals was created.
• Near-infrared light triggered CO release, with release kinetics quantified.
• In vitro studies assessed CO's effect on stem cell osteogenic differentiation.
• A rat femoral defect model was used to evaluate osseointegration in vivo.

Main Results:

• The system achieved controlled CO release (13.83 ± 1.16 μM in 10 min) upon illumination.
• Low-dose CO significantly promoted osteogenic differentiation of stem cells.
• Implants with CO release demonstrated significantly improved osseointegration in vivo.
• Comprehensive biosafety assessments confirmed excellent biocompatibility and no organ toxicity.

Conclusions:

• Controlled low-dose CO delivery via a photo-responsive implant is an effective strategy to enhance osseointegration.
• This technology offers new possibilities for improving dental and orthopedic implants, especially in challenging cases.
• The developed system shows promise for clinical translation in regenerative medicine and implantology.